Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3′,5′-monophosphate in breast cancer patients and xenograft bearing mice

Annals of Oncology

Volumn 7, Issue 3, 1996, Pages 291-296

  Cummings, J ^a   Langdon, S P ^a   Ritchie, A A ^a   Burns, D J ^a   Mackay, J ^a   Stockman, P ^a   Leonard, R C F ^a   Miller, W R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

8 chloroadenosine 3 ,5 monophosphate (8 Cl cAMP); Metabolism; Pharmacokinetics; Tumour biopsies; Xenografts

Indexed keywords

8 CHLOROADENOSINE; 8 CHLOROADENOSINE 3',5' PHOSPHATE; DRUG METABOLITE; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOPSY; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; COLON CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR XENOGRAFT;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COLONIC NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; MICE; MICE, NUDE; PRODRUGS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029874761     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010574     Document Type: Article

References (28)

1. Ally S, Clair T, Katsaros D et al. Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate. Cancer Res 1989; 49: 5650-5.
2. Cho-Chung YS. Perspectives in cancer research: Role of cyclic AMP receptor proteins in growth, differentiation and suppression of malignancy: New approaches to therapy. Cancer Res 1990; 50: 7093-100.
3. Cho-Chung YS, Clair T. The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases. Pharmacol Ther 1993; 60: 265-88.
4. Cho-Chung YS, Clair T, Tagliaferri P et al. Site selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulation. Cancer Invest 1989; 7: 161-77.
5. Bradbury AW, Miller WR, Carter DC. Cyclic adenosine 3′,5′-monophosphate binding proteins in human colorectal cancer and mucosa. Br J Cancer 1991; 63: 201-4.
6. Van Lookeren Campagne MM, Diaz FV, Jastroff B et al. 8-Chloroadenosine 3′,5′-monophosphate inhibits the growth of chinese hamster ovary and MOLT-4 cells through its adenosine metabolite. Cancer Res 1991; 51: 1600-5.
7. Langeveld CH, Jongenlen CAM, Heimans JJ et al. Growth inhibition of human glioma cells induced by chloroadenosine, an active metabolite of 8-chloro cyclic adenosine 3′,5′-monophosphate. Cancer Res 1992; 52: 3994-9.
8. Taylor CW, Yeoman LC. Inhibition of colon tumour cell growth by 8-chloro-cAMP is dependent upon its conversion to 8-chloro-adenosine. Anti-Cancer Drugs 1992; 3: 485-91.
9. Borsellino N, Crescimanno M, Leonardi V et al. Effects of 8-chloro-cyclic adenosine monophosphate on the growth and sensitivity to doxorubicin of multidrug-resistant tumour cell lines. Pharmacol Res 1994; 30: 81-90.
10. Bennett Jr LL, Chang C-H, Allan PW et al. Metabolism and metabolic effects of halopurine nucleosides in tumour cells in culture. Nucleosides and Nucleotides 1985; 4: 107-16.
11. Tagliaferri P, Katsaros D, Clair T et al. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues. Cancer Res 1988; 48: 1642-50.
12. Lange-Carter CA, Vuillequez JJ, Malkinson AM. 8-Chloroadenosine mediates 8-chloro-cyclic AMP-induced down regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism. Cancer Res 1993; 53: 393-400.
13. Cho-Chung YS. Letter to Editor. Cancer Res 1991; 51: 6206-8.
14. Kessin RH, Diaz FV, Van Lookeren Campagne MM et al. Letter to Editor. Cancer Res 1991; 51: 6209-10.
15. Cummings J. Leonard RCF, Miller WR. Preclinical pharmaceutical analysis and preliminary clinical pharmacokinetics of the signal transduction pathway modulator, 8-Cl cAMP. Ann Oncol 1994; 5 (Suppl 5): 178.
16. Saunders MP, Salisbury AJ, Harris AL et al. Phase I study of the protein kinase A regulator 8-chloro cyclic AMP. Proc Am Assoc Cancer Res 1995; 36: 241.
17. Tortora G, Ciardiello F, Pepe S et al. Phase I clinical study with 8-chloro-cAMP and evaluation of immunological effects in cancer patients. Clin Cancer Res 1995; 1: 377-84.
18. Cummings J, Leonard RCF, Miller WR. Sensitive determination of 8-chloroadenosine 3′,5′-monophosphate and 8-chloroadenosine in plasma by high-performance liquid chromatography. J Chromatogr 1994; B 658: 183-8.
19. Ramage AD, Burns DJ, Miller WR. Cyclic adenosine 3′,5′-monophosphate-binding proteins in human ovarian cancers. Br J Cancer 1994; 69: 186-90.
20. Dixit R, Lopez R, Douglas T et al. Kinetics and toxicity of 8-chloroadenosine-3′,5′-cyclic monophosphate (8-Cl-cAMP) in beagle dogs. Proc Am Assoc Cancer Res 1990; 31: 384.
21. Tomasewski JE, Sparks RM, Rose LM et al. Plasma drug levels and toxicity produced by intravenous infusions of 8-chloro-cyclic AMP (8-Cl-cAMP, NSC-614491) to beagle dogs. Proc Am Assoc Cancer Res 1991; 32: 425.
22. 3H]-S-Cl-cAMP in mice by whole-body autoradiography of cryosections. Proc Am Assoc Cancer Res 1990; 31: 382.
23. Cho-Chung YS, Clair T, Tortora G et al. Role of site selective cAMP analogues in the control and reversal of malignancy. Pharmacol Ther 1990; 50: 1-33.
24. Ciardiello F, Tortora G, Kim N et al. 8-Cl-cAMP inhibits transforming growth factor a transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation. J Biol Chem 1990; 265: 1016-20.
25. Tortora G, Yokozaki H, Pepe S et al. Differentiation of HL-60 leukaemia by type I regulatory subunit antisense oligonucleotide of cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1991; 88: 2011-5.
26. Pinto A, Aldinucci D, Gattei V et al. Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukaemia patients by site selective 8-chloro-cyclic adenosine 3′,5′-monophosphate (8-Cl-cAMP). Proc Natl Acad Sci USA 1992; 89: 8884-8.
27. Yokozaki H, Budillon A, Clair T et al. 8-Chloroadenosine 3′,5′-monophosphate as a novel modulator of multidrug resistance. Int J Oncol 1993; 3: 423-30.
28. Rohlff C, Safa B, Rahman A et al. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukaemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities. Mol Pharmacol 1993; 43: 372-9.